12:00 AM
 | 
Aug 22, 2016
 |  BC Extra  |  Financial News

ABLS spinout raises $15M in series A round

Allied Minds plc (LSE:ALM) said fibrosis and autoimmune start-up ABLS II LLC raised $15 million in a series A round. ABLS II is among three companies spun out from joint venture Allied-Bristol Life Sciences LLC, which Allied Minds formed in 2014 with Bristol-Myers Squibb Co. (NYSE:BMY), and is the first to raise a series...

Read the full 257 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >